CALGARY, AB,
June 23,
2022 /CNW/ - CanadaBis Capital Inc. (the "Company" or
"CanadaBis") (TSXV: CANB.V) a premium vertically integrated
Canadian cannabis company, is pleased to report that at our Annual
& Special Meeting (the "Meeting") held on June 23, 2022, all resolutions proposed
to shareholders were duly passed.
Shareholders approved the re-election of all individuals to the
Board of Directors of the Company, being Travis McIntyre, Gregory
Smith, Donald Cowie,
Alex Michaud, Barbara O'Neill and Shane Chana. In addition, shareholders also
approved fixing the number of directors at six, the appointment of
BDO Canada LLP as Auditors, the ratification of the amended stock
option plan and a resolution giving management the discretion to
change the Company's name at some point in the future from
"Canadabis Capital Inc." to "Stigma Cannabis Inc." should such a
change offer strategic benefit for CanadaBis.
"I am very pleased to be joined by such a skilled and dedicated
group of individuals on our Board of Directors as we move into the
next stages of our corporate evolution, which may include a name
change in the future to Stigma Cannabis should management determine
a rebrand offers incremental strategic benefit," said Travis McIntyre, President and Director of
CanadaBis. "We are grateful to have our Board's wealth of
experience, which collectively spans over 100 years across diverse
leadership roles, which will continue to be invaluable as we
navigate our growth trajectory."
ABOUT CANADABIS CAPITAL INC.
CanadaBis Capital Inc. (TSXV:CANB) is a vertically integrated
Canadian cannabis company focused on achieving large-scale growth,
from cultivation to retail, within the rapidly-emerging global
cannabis market. 100% owned subsidiary, Stigma Grow
(www.stigmagrow.ca) (1998643 Alberta Ltd.), is a cutting-edge
cannabis cultivation and extraction company positioned
advantageously to meet the unmet market demands and address legal
cannabis industry stigmas head on, with products designed to
disrupt the status quo and dramatically shift the conversation
surrounding Canada's legal
cannabis industry. Other 100% held entities include Stigma
Pharmaceuticals Inc.; Stigma Roots (Full Spectrum Labs
Ltd.) and INDICAtive Collection
(www.indicativecollection.ca) (2103157 Alberta Ltd.), along with
our 95% held subsidiary, Goldstream Cannabis Inc. By
targeting organic growth opportunities alongside the right-fit
partners, we remain focused on finding and capitalizing on
potential expansion areas and avenues for continued diversification
while continuing to prioritize becoming leaders in our
industry.
www.canadabis.com
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING
INFORMATION:
This news release includes certain "forward-looking
statements" under applicable Canadian securities legislation.
Forward-looking statements include, but are not limited to,
statements with respect to our business and operations; timing of
the Company's profitability; the demand and sales volumes of the
Company's products, and our general business plans. Forward-looking
statements are necessarily based upon a number of assumptions
including: the ability of the Company's products to compete with
the pricing and product availability on the black-market; the
market demand for the Company's products; and assumptions
concerning the Company's competitive advantages. These assumptions,
while considered reasonable, are subject to known and unknown
risks, uncertainties, and other factors which may cause actual
results and future events to differ materially from those expressed
or implied by such forward-looking statements. Such factors
include, but are not limited to: compliance with extensive
government regulation, the general business, economic, competitive,
political and social uncertainties; ability to sustain or create
demand for a product; requirement for further capital; delay or
failure to receive board, shareholder or regulatory approvals; the
results of operations and such other matters as set out in the
Company's continuous disclosure on SEDAR at www.sedar.com. There
can be no assurance that such statements will prove to be accurate,
as actual results and future events could differ materially from
those anticipated in such statements.
Accordingly, readers should not place undue reliance on
forward-looking statements. Investors are cautioned that
forward-looking information is not based on historical facts but
instead reflects management's expectations, estimates or
projections concerning future results or events based on the
opinions, assumptions and estimates of management considered
reasonable at the date the statements are made. Although we believe
that the expectations reflected in such forward-looking information
are reasonable, such information involves risks and uncertainties,
and undue reliance should not be placed on such information, as
unknown or unpredictable factors could have a material adverse
effect on our future results, performance or achievements.
Should one or more of these risks or uncertainties
materialize, or should assumptions underlying the forward-looking
information prove incorrect, actual results may vary materially
from those described herein as intended, planned, anticipated,
believed, estimated or expected. Although the Company has attempted
to identify important risks, uncertainties and factors which could
cause actual results to differ materially, there may be others that
cause results not to be as anticipated, estimated or intended.
Company does not intend, and does not assume any obligation, to
update this forward-looking information except as otherwise
required by applicable law.
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
SOURCE CanadaBis Capital Inc.